1급 영-한번역(과학기술)문제의 유형
1급 영-한번역(과학기술)문제의 유형
[1교시(공통), 제한시간 70분, 50점] * 1, 2교시 사전참고 가능
■ 다음 문장을 한국어로 번역하시오.[50점]
In the kinder, gentler, dare I say more soulful new Lara Croft movie, Angelina Jolie doesn’t just glower - she glowers with one eyebrow slightly raised. In any other movie this discreet gesture might go unnoticed, but in an industrial product like “Lara Croft Tomb Raider: The Cradle of Life,” any suggestion of humanity deserves notice. That’s especially true given that this blockbuster season has thus far been typified by what might be called post-human cinema, one in which nothing - including most of the characters - bears any resemblance to real life.
Lara Croft, of course, originated in a video game in which real life is pointedly irrelevant. What’s relevant to Lara and her legions of fans are her fantastically pneumatic breasts, her awesomely phallic weaponry and the way those breasts and weapons conspire to create a polymorphic fantasy. The target audience for point-and-shoot video games is mostly adolescent boys, but Lara’s take-charge cosmopolitan isn’t a bad fantasy for the rest of us, either. Although she’s modeled in part on the sort of colonial adventurer of which the British were once so fond, like H. Rider Haggard’s Allan Quatermain, Lara also recalls such sleek imports as Mrs. Emma Peel, the cat-suited Avenger with the long, mean kick.
Always one for a grand entrance, Ms. Lara Croft enters her new film escapade astride a Jet Ski, executing motorized flips over the Aegean like a hyperactive dolphin. Dressed in a chic black bikini that doesn’t ride up no matter what, she quickly changes into a silver wet suit that makes her look ready to pop into the microwave. Instead, bookended by a pair of strapping Greek lads, she pops into the water to go hunting for sunken treasure. She finds it, along with a mess of trouble and a cavalcade of stereotypes involving the usual faceless Asian hordes, a sinister British scientist (Ciaran Hinds), a strapping African warrior (Djimon Hounsou) and a mysterious African tribe so tolerant they don’t break stride when this freaky white woman starts bossing them around.
[2교시, 제한시간: 70분, 50점]
■ 다음 문장 중 1개의 문장만 선택하여 한국어로 번역하시오.[50점]
[1]
There are no human-health grounds for holding up the planting of transgenic crops in Britain, an expert panel has told the UK government. But the panel said that the crops could have adverse environmental impacts, and should only be grown after case-by-case assessments of the risks. Its findings, released on 21 July, are expected to influence the government's decision on whether to license some transgenic crops for commercial planting later this year. The panel was chaired by the government's chief scientific adviser, David King. Its work is part of a three-pronged assessment of transgenic crops by the UK government, which has also included a report issued on 11 July on the crops' economic impact, and a public consultation involving 500 meeting held around the country. The process is being watched closely because British consumers' rejection of the technology is influencing its adoption in many other countries. "This will be influential internationally," says plant scientist Mark Tester of the University of Cambridge. But it remains unclear whether the panel's tentative green light for the technology will be enough to open the door to British cultivation of transgenic crops any time soon. Prime Minister Tony Blair has advocated the technology, but his unpopularity in the aftermath of Iraq war may reduce the likelihood that he can persuade consumers, or environmental protesters, to accept it. The panel, which included representatives from the biotechnology industry and conservation organizations as well as university scientists, struggled to reach a consensus, its members say. on the way, they digested more than 600 papers, lost a panel member, and survival a series of last-minute revisions that threatened to scupper the entire project. "It's a minor miracle that the report got put together," says panel member Mike Gasson, head of food-safety science at the Institute of Food Research in Norwich.Carlo Leifert, an expert in organic agriculture at the University of Newcastle-upon-Tyne, quit the panel last month.
[2]
The brakes have been slammed on a major cancer-research project, after the Japan Medical Association (JMA) accused its leaders of failing to provide adequate protection for participants' privacy. The incident illuminates the distrust between physicians and clinical researchers in Japan which, observers say, continues to dog efforts to bolster the country's clinical research capacity. The cancer project seeks to study the respective roles of lifestyles and genetics in respective roles of lifestyles and genetics in determining susceptibility to major cancer types. Its planners want to collect blood samples, as well as information on diet, exercise and sleeping habits, from 100,000 subjects. The project began in May with a survey of 6,000 citizens in Kumano-cho, a small town near Hiroshima. Project organizers planned to start taking blood sample in August. But on 16 July, the Tokyo-based JMA, reacting to enquiries from Kumano-cho residents, sent a letter of complaint to the education ministry, which funds the project. The letter said that the project's data-collection process could not ensure that the personal information gathered would remain private. "They were using ordinary citizens-people who had no legal responsibility to project the information-to go to people's houses and collect it," says Rintaro Sawa, a member of the JMA's board of trustees. Sawa claims that the study took advantage of the fact that people in Hiroshima are used to answering such questions for radiation-fallout studies. The product's leaders have now told the education ministry that they will postpone the study for a year while they try to find a new way of collecting the data. one of the project leaders, Kei Nakachi, a cancer epidemiologist at the Radiation Efforts Research Foundation in Hiroshima, says he accepts the JMA's critique. "We want to be honest and open look at our problems,"he says. But some researchers are perplexed by the watchdog role that the JMA seems to be assuming over their work.
[3]
High rates of drug resistance are causing infectious-disease experts to recommend that doctors change the way they use medications against HIV. A study released on 16 July by Charles Boucher, a virologist at Utrecht University in the Netherlands, at a meeting in Paris of the International AIDS Society (IAS), found that 10% of Europeans newly infected with HIV carry a strain that is resistant to medication. The study confirms warnings that HIV drug resistance is on the rise. Last August , for example, a team led by researchers from the University of San Diego found that the number of patients newly infected with HIV in North America who carried resistant virus had jumped from 3.4% in 1995-98 to 12.4% in 1999 and 2000 (S. J. Little et al. N. Engl. J. Med. 347, 385-395 : 2002). The growth of resistance has profound implications for AIDS treatment globally, researchers say. on 14 July, the US Department of Health and Human Services released a set of updated guidelines for anti-retroviral treatments, cautiously recommending for the first time that doctors test for drug resistance in newly infected patients at the outset of treatment, to make sure that the drugs they prescribe will work. A panel of experts convened by the IAS on 1 July published similar recommendation (M. S. Hirsch et al. Clin. Infect. Dis. 37, 113-128 ; 2003). The IAS panel said that all patients who have been infected for less than two years before beginning treatment should be tested for drug resistance. Virologists have found that drug-resistant forms of HIV can survive in patients for at least two years , and are still studying whether resistance can last longer than that. Most doctors use drug-resistance tests only in HIV patients who have several rounds of drug treatment and stopped responding. This is because the tests cost up to ￥800 per patients, and are sometimes difficult for clinicians to interpret. But better tools are as drug resistance becomes more common, testing will become more cost-effective.
1급 영-한번역(과학기술)문제의 유형
[1교시(공통), 제한시간 70분, 50점] * 1, 2교시 사전참고 가능
■ 다음 문장을 한국어로 번역하시오.[50점]
In the kinder, gentler, dare I say more soulful new Lara Croft movie, Angelina Jolie doesn’t just glower - she glowers with one eyebrow slightly raised. In any other movie this discreet gesture might go unnoticed, but in an industrial product like “Lara Croft Tomb Raider: The Cradle of Life,” any suggestion of humanity deserves notice. That’s especially true given that this blockbuster season has thus far been typified by what might be called post-human cinema, one in which nothing - including most of the characters - bears any resemblance to real life.
Lara Croft, of course, originated in a video game in which real life is pointedly irrelevant. What’s relevant to Lara and her legions of fans are her fantastically pneumatic breasts, her awesomely phallic weaponry and the way those breasts and weapons conspire to create a polymorphic fantasy. The target audience for point-and-shoot video games is mostly adolescent boys, but Lara’s take-charge cosmopolitan isn’t a bad fantasy for the rest of us, either. Although she’s modeled in part on the sort of colonial adventurer of which the British were once so fond, like H. Rider Haggard’s Allan Quatermain, Lara also recalls such sleek imports as Mrs. Emma Peel, the cat-suited Avenger with the long, mean kick.
Always one for a grand entrance, Ms. Lara Croft enters her new film escapade astride a Jet Ski, executing motorized flips over the Aegean like a hyperactive dolphin. Dressed in a chic black bikini that doesn’t ride up no matter what, she quickly changes into a silver wet suit that makes her look ready to pop into the microwave. Instead, bookended by a pair of strapping Greek lads, she pops into the water to go hunting for sunken treasure. She finds it, along with a mess of trouble and a cavalcade of stereotypes involving the usual faceless Asian hordes, a sinister British scientist (Ciaran Hinds), a strapping African warrior (Djimon Hounsou) and a mysterious African tribe so tolerant they don’t break stride when this freaky white woman starts bossing them around.
[2교시, 제한시간: 70분, 50점]
■ 다음 문장 중 1개의 문장만 선택하여 한국어로 번역하시오.[50점]
[1]
There are no human-health grounds for holding up the planting of transgenic crops in Britain, an expert panel has told the UK government. But the panel said that the crops could have adverse environmental impacts, and should only be grown after case-by-case assessments of the risks. Its findings, released on 21 July, are expected to influence the government's decision on whether to license some transgenic crops for commercial planting later this year. The panel was chaired by the government's chief scientific adviser, David King. Its work is part of a three-pronged assessment of transgenic crops by the UK government, which has also included a report issued on 11 July on the crops' economic impact, and a public consultation involving 500 meeting held around the country. The process is being watched closely because British consumers' rejection of the technology is influencing its adoption in many other countries. "This will be influential internationally," says plant scientist Mark Tester of the University of Cambridge. But it remains unclear whether the panel's tentative green light for the technology will be enough to open the door to British cultivation of transgenic crops any time soon. Prime Minister Tony Blair has advocated the technology, but his unpopularity in the aftermath of Iraq war may reduce the likelihood that he can persuade consumers, or environmental protesters, to accept it. The panel, which included representatives from the biotechnology industry and conservation organizations as well as university scientists, struggled to reach a consensus, its members say. on the way, they digested more than 600 papers, lost a panel member, and survival a series of last-minute revisions that threatened to scupper the entire project. "It's a minor miracle that the report got put together," says panel member Mike Gasson, head of food-safety science at the Institute of Food Research in Norwich.Carlo Leifert, an expert in organic agriculture at the University of Newcastle-upon-Tyne, quit the panel last month.
[2]
The brakes have been slammed on a major cancer-research project, after the Japan Medical Association (JMA) accused its leaders of failing to provide adequate protection for participants' privacy. The incident illuminates the distrust between physicians and clinical researchers in Japan which, observers say, continues to dog efforts to bolster the country's clinical research capacity. The cancer project seeks to study the respective roles of lifestyles and genetics in respective roles of lifestyles and genetics in determining susceptibility to major cancer types. Its planners want to collect blood samples, as well as information on diet, exercise and sleeping habits, from 100,000 subjects. The project began in May with a survey of 6,000 citizens in Kumano-cho, a small town near Hiroshima. Project organizers planned to start taking blood sample in August. But on 16 July, the Tokyo-based JMA, reacting to enquiries from Kumano-cho residents, sent a letter of complaint to the education ministry, which funds the project. The letter said that the project's data-collection process could not ensure that the personal information gathered would remain private. "They were using ordinary citizens-people who had no legal responsibility to project the information-to go to people's houses and collect it," says Rintaro Sawa, a member of the JMA's board of trustees. Sawa claims that the study took advantage of the fact that people in Hiroshima are used to answering such questions for radiation-fallout studies. The product's leaders have now told the education ministry that they will postpone the study for a year while they try to find a new way of collecting the data. one of the project leaders, Kei Nakachi, a cancer epidemiologist at the Radiation Efforts Research Foundation in Hiroshima, says he accepts the JMA's critique. "We want to be honest and open look at our problems,"he says. But some researchers are perplexed by the watchdog role that the JMA seems to be assuming over their work.
[3]
High rates of drug resistance are causing infectious-disease experts to recommend that doctors change the way they use medications against HIV. A study released on 16 July by Charles Boucher, a virologist at Utrecht University in the Netherlands, at a meeting in Paris of the International AIDS Society (IAS), found that 10% of Europeans newly infected with HIV carry a strain that is resistant to medication. The study confirms warnings that HIV drug resistance is on the rise. Last August , for example, a team led by researchers from the University of San Diego found that the number of patients newly infected with HIV in North America who carried resistant virus had jumped from 3.4% in 1995-98 to 12.4% in 1999 and 2000 (S. J. Little et al. N. Engl. J. Med. 347, 385-395 : 2002). The growth of resistance has profound implications for AIDS treatment globally, researchers say. on 14 July, the US Department of Health and Human Services released a set of updated guidelines for anti-retroviral treatments, cautiously recommending for the first time that doctors test for drug resistance in newly infected patients at the outset of treatment, to make sure that the drugs they prescribe will work. A panel of experts convened by the IAS on 1 July published similar recommendation (M. S. Hirsch et al. Clin. Infect. Dis. 37, 113-128 ; 2003). The IAS panel said that all patients who have been infected for less than two years before beginning treatment should be tested for drug resistance. Virologists have found that drug-resistant forms of HIV can survive in patients for at least two years , and are still studying whether resistance can last longer than that. Most doctors use drug-resistance tests only in HIV patients who have several rounds of drug treatment and stopped responding. This is because the tests cost up to ￥800 per patients, and are sometimes difficult for clinicians to interpret. But better tools are as drug resistance becomes more common, testing will become more cost-effective.
'번역사 > 번역사 기출문제 영어' 카테고리의 다른 글
| [영어영상번역작가학원]제18회 번역능력인정시험 1급 영.한 번역(분야구분 (0) | 2008.06.10 |
|---|---|
| [영어영상번역가학원]번역능력인정시험 영어 3급 1교시 예시문제 (0) | 2008.06.10 |
| [영어번역기출문제]2급 한-영번역 문제의 유형 (0) | 2008.06.10 |
| [영어번역작가학원]영어3급 [1교시 문제]의 유형 번역 (0) | 2008.06.10 |
| [영어번역사전문학원]영어3급 [1교시 문제]의 유형 번역 (0) | 2008.06.10 |